CRSP EBITDA
Crispr Therapeutics Ag · EBITDA
CRSP EBITDA
Latest reported-$110.52Mperiod ending
CRSP Quarterly EBITDA (-$3.72M → -$110.52M)
Quarterly EBITDA
High-resolution chart · PNG
CRSP ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -110,516,000 | |
| -117,773,000 | |
| -124,338,000 | |
| -101,389,000 | |
| -202,608,000 | |
| -130,151,000 | |
| -31,769,000 | |
| -80,327,000 | |
| -120,276,000 | |
| -111,034,000 | |
| 94,480,000 | |
| -106,815,000 | |
| -71,856,000 | |
| -46,694,000 | |
| -114,205,000 | |
| -170,106,000 | |
| -172,447,000 | |
| -169,570,000 | |
| -132,734,001 | |
| -122,424,000 | |
| 767,021,000 | |
| -111,828,000 | |
| -105,195,000 | |
| -90,064,000 | |
| -78,497,000 | |
| -71,495,000 | |
| 12,415,000 | |
| 140,446,000 | |
| -53,785,000 | |
| -47,611,000 | |
| -51,036,000 | |
| -48,549,000 | |
| -36,421,000 | |
| -26,171,000 | |
| 1,778,000 | |
| -22,778,000 | |
| -20,600,000 | |
| -20,024,000 | |
| -22,898,000 | |
| -14,449,000 | |
| -16,993,000 | |
| -11,692,000 | |
| -12,058,000 | |
| -6,153,000 | |
| -3,611,000 | |
| -3,722,000 |